Intranasal Corticosteroids Market Size

Intranasal Corticosteroids Market size was valued at USD 7.13 billion in 2024 and is likely to cross USD 13.61 billion by 2037, registering more than 5.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of intranasal corticosteroids is estimated at USD 7.44 billion.
 

The growth of the market can be attributed to the growing prevalence of sinusitis across the globe. Data published by the National Library of Medicine showed that in 2022, around 90% of people having a cold showed the symptoms of viral sinusitis.

Furthermore, the global intranasal corticosteroids market is expanding its size exponentially on the back of rising cases of cold and fever. Nasal corticosteroids, a member of the steroids family, are cortisone-like medicine and can be administered by two methods, sprayed and inhaled. Nasal corticosteroids are utilized by people to prevent irritation, discomfort, stuffy nose, and another sort of allergies. The expansion in the global intranasal corticosteroids market size is backed by the frequently occurring nasal problems such as sinus infection, airway blockage, congestion, and others.  For instance, it is observed that around 0.6% of respiratory tract infections are caused by sinusitis and it can range from 20 to 45 episodes per 1000 individuals annually.